Please login to the form below

Not currently logged in
Email:
Password:

antibodies

This page shows the latest antibodies news and features for those working in and with pharma, biotech and healthcare.

GSK’s myeloma drug hits target, prompting rapid filing pledge

GSK’s myeloma drug hits target, prompting rapid filing pledge

Antibody drug conjugate could challenge CAR-Ts. GlaxoSmithKline has unveiled some robust data for its multiple myeloma antibody drug conjugate, and chief scientific officer Dr Hal Barron has pledged a rapid ... GSK2857916 is an anti-B-cell maturation

Latest news

More from news
Approximately 15 fully matching, plus 889 partially matching documents found.

Latest Intelligence

  • Where next in Alzheimer’s disease R&D? Where next in Alzheimer’s disease R&D?

    The drugs include antibodies that capture tau as it spreads between cells and small molecules designed to enter cells and inhibit tau aggregation. ... AbbVie is testing its anti-tau antibody ABBV-8E12 in a phase 2 trial, while Biogen has links to two

  • Cell and gene therapy Cell and gene therapy

    Also, as Sinclair points out, strategies like process scale-up that have been used to reduce the cost of making a monoclonal antibody to $50-200 per dose cannot really be

  • Drug launches to watch in 2019 Drug launches to watch in 2019

    Takhzyro is the first antibody to be approved for HAE in a market of a handful of existing treatments, including Shire’s three existing products, Cinryze, Firazyr and Kalbitor), that collectively

  • AstraZeneca’s oncology renaissance AstraZeneca’s oncology renaissance

    Finally, there are antibody drug conjugate programmes led out of MedImmune.

  • Combined immunotherapies – potential and pitfalls Combined immunotherapies – potential and pitfalls

    The recent failed phase 3 trial of a combination of MSD’s monoclonal antibody Keytruda (pembrolizumab) and InCyte Corporation’s epacadostat in metastatic melanoma is a case in point he says. ... This has shaped industry development strategies, said

More from intelligence
Approximately 1 fully matching, plus 102 partially matching documents found.

Latest appointments

More from appointments
Approximately 1 fully matching, plus 32 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 17 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
mXm Medical Communications

mXm Medical Communications meets the needs of pharmaceutical marketers and medics who require a highly experienced, bespoke service from their...

Latest intelligence

50 questions for delivering an exceptional healthcare brand experience
Our 50-question brand planning checklist for healthcare ensures you deliver an exceptional experience, based on what your stakeholders want and need...
The brand strategy revolution
Introducing a new tool for developing a stakeholder-centric brand, based on the experience your patients and their HCPs want and need....
How Medisafe is using AI to improve patient adherence
Dina Patel speaks to Omri Shor, Co-Founder and CEO of Medisafe, to find out how his medication management app is tackling the problem of poor adherence....

Infographics